The changes of CDH1, CDH2, and PLK1 in the TGF-β-treated NSCLC cells were consistent with the alterations in the published transcriptome of TGF-β-treated cells (GSE 114761) (Fig. 1d, e). Here, CDH1 is linked to non-small cell lung carcinoma.